Sign in
CompletedPhase 1

A study to test a single administration of three dose levels of ATX101 in healthy adults.

Key facts

Who runs it
Aurobac Therapeutics S.A.S.
Where
Portugal1 site in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 1
People taking part
24 people enrolled
Started
16 Jul 2025
Ended
24 Oct 2025
Type of study
Interventional
Record updated
10 October 2025

Who can take part

Age
18 years to 64 years
Sex
Women and men
Healthy volunteers
Can take part

Where is this trial?

It has sites in one country. Choose a country to see its sites.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Record updated
10 October 2025